Fernando Pérez-Ruiz, MD, PhD

Fernando Pérez-Ruiz, MD, PhD, is a Consultant of the Rheumatology Division in Hospital Universitario Cruces, Head of the Investigation Group for Arthritis at Biocruces Health Research Institute, and Associated Professor of the Department of Medicine in School of Medicine and Nursery at the Basque Country University in Biscay, Spain.

He received his MD from Basque Country University and a PhD in from Barcelona University with a clinical investigation program on classification and treatment of hyperuricemia in gout. Board certified in Rheumatology after a fellowship at Hospital Ramón y Cajal in Madrid through qualifying in the national exam for specialty within the top20.

He has collaborated with the European League Against Rheumatism (EULAR) 2006 and 2016 recommendations for Gout management, the ACR Guidelines for gout 2012, the OMERACT special interest group for gout, and the T2T 2016 initiative for gout. He founded and coordinated the Crystal-induced Arthritis Study Group of the SER (Spanish Society for Rheumatology) and coordinates the SER-Guidelines and updates for the management of gout.
Has served as vice president of SER from 2014 to 2018 in charge of education programs and as delegate at EULAR of the Spanish SER presidency and in the education and the investigation committees. Member of the advisory Committee for rheumatology fellowship at the Spanish Health Ministry 2014 to 2016 and member of the Corporative Pharmacy Commission in the Basque Health Department of the Basque Government.

He has served for the last years as associated editor and editorial boards of several indexed journals and as an invited reviewer for more than 30 international journals and is an active member of the editorial board of Springer´s Medicine Matters Rheumatology and Wolters-Kluwer´s Up-to-Date.

His research interests include crystal-induced arthritis, and especially gout, but has also investigated and published on CPPD, lupus, rheumatoid arthritis, and fibromyalgia. Dr. Pérez-Ruiz has delivered over 100 lectures, published 144 indexed articles and 21 book chapters, presenting over 250 scientific abstracts in rheumatology meetings on topics relating to diverse rheumatology diseases, but mostly gout, gathering a cumulated impact factor over 1,500, and h-index 48.